Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00492505
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2007-06-25
Brief Title:
Sorafenib Tamoxifen and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Sponsor:
Organization:
National Cancer Institute NCI